References
- 1. Astin R, Puthucheary Z. Anaemia secondary to critical illness: an unexplained phenomenon. Extrem Physiol Med. 2014;3:4.
- 2. Thomas J, Jensen L, Nahirniak S, Gibney RT. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Heart Lung. 2010;39:217-25.
- 3. Hajjar LA, Auler Junior JO, Santos L, Galas F. Blood tranfusion in critically ill patients: state of the art. Clinics (Sao Paulo). 2007;62:507-24.
- 4. Athar MK, Puri N, Gerber DR. Anemia and Blood Transfusions in Critically Ill Patients. Journal of blood transfusion. 2012;2012:629204.
- 5. McEvoy MT, Shander A. Anemia, bleeding, and blood transfusion in the intensive care unit: Causes, risks, costs, and new strategies. Am J Crit Care. 2013;22:eS1-13.
- 6. Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care. 2006;10:R140.
- 7. Harber CR, Sosnowski KJ, Hegde RM. Highly conservative phlebotomy in adult intensive care-a prospective randomized controlled trial. Anaesth Intensive Care. 2006;34:434-7.
- 8. Arnold DM, Donahoe L, Clarke FJ, et al. Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med. 2007;30:E93-E102.
- 9. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program. 2010;2010:135-43.
- 10. Marks PW. Coagulation disorders in the ICU. Clin Chest Med. 2009;30:123-9.
- 11. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24-33.
- 12. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation Canadian Critical Care Trials Group. Crit Care Med. 1999;27:2812-7.
- 13. Jelkmann I, Jelkmann W. Impact of Erythropoietin on Intensive Care Unit Patients. Transfus Med Hemother. 2013;40:310-8.
- 14. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16:36-41.
- 15. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr Opin Hematol. 2005;12:123-8.
- 16. Lasocki S, Longrois D, Montravers P, Beaumont C. Hepcidin and anemia of the critically ill patient: bench to bedside. Anesthesiology. 2011;114:688-94.
- 17. Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion. 2012;52:1584-92.
- 18. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program. 2011;2011:538-42.
- 19. Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A. Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology. 2010;112:1211-5.
- 20. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care. 2001;29:473-8.
- 21. Bellamy MC, Gedney JA. Unrecognised iron deficiency in critical illness. Lancet. 1998;352(9144):1903.
- 22. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012;11: 635-42.
- 23. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med. 2012;185:1049-57.
- 24. De Souza DA, Silva FG e, Costa PJM de S. Critical evaluation of justifications for the transfusion of red blood cells: the reality of a government emergency hospital. Rev Bras Hematol Hemoter. 2013;35:263-7.
- 25. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209-20.
- 26. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119:1757-67.
- 27. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested casecontrol study. Blood. 2011;117:4218-25.
- 28. Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012;52:160-5.
- 29. Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51:338-43.
- 30. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327-48.
- 31. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a metaanalysis and systematic review. Am J Med. 2014;127:124-31.
- 32. Stubbs JR. Alternatives to blood product transfusion in the critically ill: erythropoietin. Crit Care Med. 2006;34:S160-9.
- 33. Corwin HL. The role of erythropoietin therapy in the critically ill. Transfus Med Rev. 2006;20:27-33.
- 34. Jelkmann I, Jelkmann W. Impact of Erythropoietin on Intensive Care Unit Patients. Transfus Med Hemother. 2013;40:310-8.
- 35. Moore EE, Moore FA, Fabian TC, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208:1-13.
- 36. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299:2304-12.
- 37. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 2008;64:1484-97.
- 38. Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11:482-7.
- 39. Weinberg ED. Iron loading and disease surveillance. Emerg Infect Dis. 1999;5:346-52.